Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Early recognition, prevention, and management of glucocorticoid toxicity in patients with rheumatic diseases.
Journal: Expert opinion on drug safety
Published: August 19, 2026
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor.
Journal: Rheumatology and therapy
Published: April 15, 2026
The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics-Real-world Evidence from 2018 to 2022.
Journal: European urology open science
Published: January 25, 2024
Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
Journal: BMC urology
Published: January 15, 2024
Improved prostate cancer diagnostics with a structured pathway including »Stockholm 3« test, MRI and targeted perineal biopsies
Journal: Lakartidningen
Published: August 22, 2023
One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib.
Journal: Advances in therapy
Published: April 06, 2023
Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study.
Journal: Rheumatology and therapy
Published: March 28, 2023
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
Journal: Arthritis research & therapy
Published: November 04, 2022
Media use and trust during the COVID-19 pandemic: evidence from eight cross-sectional surveys in Sweden.
Journal: European journal of public health
Published: October 12, 2022
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.
Journal: Rheumatology and therapy
Published: September 22, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.
Journal: Rheumatology and therapy
Published: May 12, 2022
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis.
Journal: The Journal of rheumatology
Published: March 29, 2022
Last Updated: 09/26/2026